Purpose This study aimed to determine whether there is a relationship between iron status and bone metabolism, and to compare the effects of the consumption, as part of the usual diet, of an iron or iron and vitamin D-fortified skimmed milk on bone remodelling in iron-deficient women. Methods Young healthy iron-deficient or iron-sufficient women (serum ferritin B30 ng/mL or [30 ng/mL, respectively) were recruited. Iron-deficient women were assigned to a nutritional intervention consisting of a randomised, controlled, double-blind, parallel design trial of 16 weeks during winter. They consumed, as part of their usual diet, an iron (Fe group, n = 54) or iron and vitamin D-fortified (Fe?D group, n = 55) flavoured skimmed milk (iron, 15 mg/day; vitamin D 3 , 5 lg/day, 200 IU). The ironsufficient women followed their usual diet without supplementation (R group, n = 56). Dietary intake, body weight, iron biomarkers, 25-hydroxyvitamin D (25OHD), parathyroid hormone (PTH), procollagen-type 1 N-terminal propeptide (P1NP), and aminoterminal telopeptide of collagen I (NTx) were determined. Results Negative correlations were found between baseline log-ferritin and log-NTx (p \ 0.001), and between transferrin and P1NP (p = 0.002). Serum 25OHD increased (from 62 ± 21 to 71 ± 21 nmol/L, mean ± SD, p \ 0.001) while P1NP and NTx decreased in Fe?D during the assay (p = 0.004 and p \ 0.001, respectively). NTx was lower in Fe?D compared to Fe at week 8 (p \ 0.05) and was higher in Fe and Fe?D compared to R throughout the assay (p \ 0.01). PTH did not show changes. Conclusions Iron deficiency is related with higher bone resorption in young women. Consumption of a dairy product that supplies 5 lg/day of vitamin D 3 reduces bone turnover and increases circulating 25OHD to nearly reach an optimal vitamin D status, defined as 25OHD over 75 nmol/L.
Introduction
Vitamin D deficiency is found in most countries all over the word and it is recognised as a pandemic problem [1] . Effects of vitamin D on bone health are well known. The primary effect of vitamin D is to enhance calcium absorption in the small intestine. Thus, vitamin D deficiency leads to decreased calcium absorption and calcium release from bone in order to maintain circulating concentrations [2] . Prolonged and severe vitamin D deficiency causes rickets in children and osteomalacia in adults [3] . Recently, vitamin D deficiency has also been associated with other disorders such as cancer, diabetes, hypertension, and autoimmune diseases [4] .
Another important global health problem is iron deficiency anaemia. A relationship between iron and vitamin D deficiencies has been proposed [5] . Low 25-hydroxyvitamin D (25OHD) levels have been associated with low levels of erythrocytes, serum iron, and transferrin saturation, suggesting that vitamin D has an effect on erythropoiesis [6] [7] [8] . Regarding the possible role of iron in bone metabolism, it is known that this metal is a cofactor of prolyl and lysyl hydroxylases in collagen synthesis that play an important role in collagen maturation [9] . Studies in rats have shown that severe iron deficiency anaemia has a significant impact on bone, affecting bone mineralization [10] [11] [12] , and there is one study in humans that found a positive association between dietary iron and bone mineral density in healthy postmenopausal women [13] .
The main source of vitamin D for humans is sun exposure [14] . Even though Spain is a country with many hours of sunshine, studies have shown a high prevalence of vitamin D deficiency [15] [16] [17] . Blanco-Rojo et al. [8] found a very high prevalence of vitamin D deficiency or insufficiency (92 %) in a group of iron-deficient Spanish women.
Food fortification is probably the most practical and cost-effective prevention programme for correcting iron deficiency [18] , and fortification with vitamin D is also a good strategy when sun exposure is limited, as few foods naturally contain this vitamin [1, 19] . However, except for infant formulas, very few products are fortified with both iron and vitamin D.
There are no reports regarding the effects of the intake of iron-fortified skimmed milk and the additional effects of the simultaneous fortification with vitamin D, on bone metabolism in iron-deficient subjects. Therefore, the aims of this study were: (a) to determine whether there is a relationship between iron status and bone remodelling in menstruating women, and (b) to compare the effects of the consumption, as part of the usual diet, of an iron or iron and vitamin D-fortified flavoured skimmed milk on bone metabolism in iron-deficient women.
Methods

Subjects
Volunteers were recruited by different announcements in press, university campus, and web pages of Madrid. The study was also verbally promoted at public events.
Healthy women aged 18-35 years, Caucasian, nonsmoker, non-pregnant, non-breastfeeding were recruited. Those with low iron stores (serum ferritin B30 ng/mL, haemoglobin C11 g/dL) were assigned to the nutritional intervention and those with normal iron stores (serum ferritin [30 ng/mL, haemoglobin [11 g/dL) formed the reference group (R group) who followed their usual diet without supplementation.
For all subjects, the exclusion criteria were as follows: amenorrhoea, menopause, any known health problems likely to influence iron status including iron metabolismrelated diseases (iron deficiency anaemia, thalassaemia, haemochromatosis), chronic gastric diseases (inflammatory bowel disease, Crohn disease, gastric ulcers, coeliac disease, haemorrhagic diseases, Helicobacter pylori), renal disease, blood donors, or regular consumption of iron supplements within the 4 months prior to participating in the study. For the nutritional intervention groups, another exclusion criterion was to be allergic to any of the components of the assayed dairy products.
A total of 584 women contacted the research group to receive information and 289 underwent the screening. Women who did not meet the inclusion criteria or declined to participate were excluded (n = 104). Finally, a total of 129 iron-deficient women agreed to participate in the nutritional intervention and were randomly distributed into two groups (Fe or Fe?D), and 56 iron-sufficient women were included in the reference group (R). During the study, 16 women abandoned the nutritional intervention and 4 were excluded due to lack of compliance. Therefore, 109 women completed the study and were analysed (Fe, n = 55 and Fe?D, n = 54). There were no dropouts in the R group.
The present study was conducted according to the guidelines laid down in the Declaration of Helsinki, and all procedures involving human subjects were approved by the Clinical Research Ethics Committee of Hospital Puerta de Hierro, Majadahonda, and the Spanish National Research Council Committee, Madrid, Spain. All subjects signed written informed consent forms.
Nutritional intervention design
The study was performed in Madrid, Spain (latitude: 40.24°N), and consisted of a randomised, controlled, double-blind, parallel design trial of 16 weeks duration during the winter season.
Participants were randomly distributed into two groups, using the RAND function of Excel (Microsoft Office 2010). One group consumed, as part of their usual diet, 500 mL/day of the iron-fortified dairy product (Fe group, n = 54), whereas the other consumed 500 mL/day of the iron ? vitamin D-fortified dairy product (Fe?D group, n = 55).
The Fe and Fe?D-fortified dairy products were manufactured from skimmed flavoured milk in 500-mL cartons in vanilla flavour. Both dairy products supplied 15 mg Fe/500 mL carton, in the form of microencapsulated iron pyrophosphate coated with lecithin, equivalent to 83, 3 % of the recommended dietary allowance (RDA) per day [20, 21] . The Fe?D-fortified dairy product additionally provided 200 IU (5 lg) of vitamin D 3 /500 mL carton, equivalent to 100 % of the RDA/day [22] . Both products provided (per 100 mL): 37 kcal (156 kJ), 3.1 g of protein, 5.4 g of carbohydrates, 0.3 g of fat, 120 mg of calcium (data provided by the manufacturer, CAPSA, Spain). Analytical concentration of iron (atomic absorption spectrometry, Perkin Elmer 5100 PC) was 3.10 and 2.94 mg per 100 mL, for the Fe and Fe?D products, respectively, and vitamin D 3 (Mass Spectrometer, Agilent LC QQQ 6460) in the Fe?D product was 0.99 lg per 100 mL.
Participants were instructed to consume one 500 mL carton every day, all at once separately from meals (by at least 2 h) and had to shake it before consumption. Volunteers who could not drink the dairy product one day were instructed to consume two cartons the following day.
Dietary control and compliance and anthropometric determinations
All participants, intervention and reference groups, were instructed not to deviate from their regular habits and to maintain their normal diet and exercise level during the 4 months.
Dietary intake was evaluated at baseline and at 8 and 16 weeks to control any possible changes in energy and nutrient intake. Subjects completed a 72-h detailed dietary intake report specifying the types of food consumed and serving weights. Daily food, energy intake, nutrient intake, and energy provided by macronutrients were calculated by a computer application using the Spanish Food Composition Database (DIAL, Alce Ingeniería). The compliance of the nutritional intervention and the follow-up of the reference group were assessed bimonthly by questionnaires and a personal interview when volunteers underwent blood sampling.
At baseline, body weight was measured with a Seca scale (to a precision of 100 g) and height was measured with a stadiometer incorporated into the scale. Body mass index (BMI) was calculated. In addition, volunteers completed a questionnaire every 2 months in order to monitor possible health problems, medication use, and changes in their normal routine.
Blood sampling and biochemical determinations
All volunteers attended the laboratory facilities at baseline and at weeks 8 and 16. Blood samples were collected by venepuncture after a 12-h fasting period. Serum was obtained after centrifugation at 1,000 g for 15 min and the second morning urine was also collected to analyse the bone resorption marker (aminoterminal telopeptide of collagen I, NTx). High-quality results are obtained from 24-h urine as well as second morning urine samples; thus, this was selected because it was easier to control and to be collected by the volunteer. Both samples were stored at -80°C.
Serum 25OHD concentration (25-hydroxyvitamin D 2 plus 25-hydroxyvitamin D 3 ) was determined by an ELISA commercial kit, with intra-and inter-assay coefficients of variation of 5.6 and 6.4 %, respectively (25-hydroxyvitamin D EIA, Immunodiagnostic Systems, IDS, United Kingdom). The bone resorption marker, urine aminoterminal telopeptide of collagen I (NTx), was determined in the second morning urine by an ELISA commercial kit with intra-and inter-assay coefficients of variation of 5.0 and 5.5 %, respectively (Osteomark Ò NTx Urine, Wampole Laboratories, USA). NTx is expressed as nanomoles of bone collagen equivalents per litre per millimol of creatinine per litre (nM BCE/mM Cr). Urinary creatinine levels were measured using an autoanalyser method (modular Roche DDPP). Intra-and inter-assay coefficients of variation of the method were \0.7 and \2.3 %, respectively. The bone formation marker procollagen-type 1 N-terminal propeptide (P1NP) and parathyroid hormone (PTH) were determined in serum by electrochemiluminescence (Elecsys, Roche Diagnostics, USA). Intra-and inter-assay coefficients of variation for P1NP were 2.6 and 4.1 %, respectively, and for PTH were 2.7 and 6.5 %, respectively. All determinations of the same parameter of each person were carried out in the same run to avoid interassay error.
Haemoglobin was determined in whole blood following standard laboratory techniques using the Symex NE 9100 automated haematology analyser (Symex, Kobe, Japan). Serum iron, serum ferritin, and serum transferrin were determined by the Modular Analytics Serum Work Area analyser (Roche, Basel, Switzerland). Total iron binding capacity (TIBC) and transferrin saturation were calculated as follows: TIBC (lmol/L) = 25.19 transferrin (g/L); transferrin saturation = serum iron (lmol/L)/TIBC 9 100.
All determinations were subject to the ISO-9001-2000 requirements.
Statistical analysis
Data are presented as means with their standard deviations. A normal distribution of variables was determined by the Kolmogorov-Smirnov test. Urine NTx and serum ferritin values were log-transformed for statistical testing. Pearson's linear correlation tests between iron and bone variables were performed at baseline. Linear regression was performed for those parameters with significant correlations.
Repeated measures analysis of variance (ANOVA) and post hoc Bonferroni test were used to study time effect within groups. Comparisons were also made at each time
A p value of \0.05 was considered significant. The SPSS statistical package for Windows (version 20.0) was used to analyse the data.
Results
A total of 165 women completed the study. Ages of the volunteers were 24.8 ± 4.1, 24.7 ± 4.6, and 26.5 ± 3.8 years, and BMI were 21.9 ± 3.0, 21.4 ± 3.0, and 22.4 ± 3.2 kg/m 2 , for the Fe, Fe?D, and R groups, respectively, without significant differences between groups for either parameter. Tables 1 and 2 
0.001), and transferrin saturation (p = 0.002) showed significant differences between groups without differences between the Fe and the Fe?D groups. Haemoglobin levels were similar in the three groups and reflected normal values.
Significant negative correlations were found between baseline log-ferritin and log-NTx (R 2 = 0.079, p \ 0.001), and between P1NP and transferrin (R 2 = 0.058, p = 0.002) for all volunteers (Figs. 1, 2) . Table 3 presents changes in bone turnover biomarkers during 16 weeks for the iron-deficient women consuming Fe or Fe?D dairy products and for the R group. Serum 25OHD significantly increased in the Fe?D group during the assay (p \ 0.001) and at weeks 8 and 16, it was significantly higher compared to the R group (p \ 0.01). In the Fe group, it presented a decrease at week 8 but at the end of the study, it recovered baseline levels (p = 0.01). The R group showed the same evolution, although time differences were not significant. PTH did not show changes throughout the intervention in any of the groups.
There were no time changes in P1NP in the Fe and R groups. However, in Fe?D group, it progressively decreased during the assay (p = 0.004), although the differences between groups did not reach significance.
NTx values were higher at baseline and at weeks 8 and 16 in Fe and Fe?D compared to the R group (p \ 0.01). NTx levels significantly decreased during the intervention in the Fe?D group (p \ 0.001), and they were significantly lower compared to Fe group at week 8 (p \ 0.05). The Fe and R groups did not present time changes throughout the study for this parameter.
Discussion
Present results show for the first time a relationship between iron biomarkers and bone turnover markers in a group of young menstruating Spanish women. A negative correlation between ferritin, the best biomarker of iron stores, and NTx, which reflects bone resorption, was observed in these women. The observed statistical power of the regression test, obtained with the 165 subjects, was 95.9 %. This is consistent with the higher bone resorption observed in the two groups of women with iron deficiency compared to the iron-sufficient group. Studies in young women are scarce. NTx values of around 25 nmoL BCE/nmol have been reported for healthy young women with age and BMI similar to the present assay [23] , which is consistent with the NTx results of the R group. However, the high NTx levels of the Fe and Fe?D groups are in agreement with previous observations in iron-deficient women [8] .
A negative association between transferrin, which is the main iron transporter protein to tissues, and P1NP, a bone formation marker, was found in this study. The observed statistical power of the regression test in this case was 88.2 %. However, differences between groups were not significant during the intervention. To the best of our knowledge, there is limited information regarding bone remodelling in iron-deficient women. In a group of osteoporotic postmenopausal women, D'Amelio et al. [24] found an inverse correlation between transferrin and lumbar and femoral bone mineral density. Some other studies in rats show that severe anaemia decreases bone formation, evaluated by P1NP [10] and osteocalcin [11] , and increases bone resorption, measured by urinary C-terminal telopeptides of type I collagen (CTx) [10, 11] which is in agreement with our baseline results. However, the relationship between iron and bone markers is still controversial, and other reports show no effect on osteocalcin [25] while urinary deoxypyridinoline (DPD), marker of bone resorption, shows no change [25] or even a decrease [11, 12] . Results in the present study support previous findings that iron deficiency involves alterations in bone metabolism.
The higher bone resorption in the iron-deficient groups compared to the R group cannot be attributed to PTH action as PTH levels were within the normal range without significant differences between groups. Moreover, all volunteers were healthy and their calcium intake was adequate. This is also supported by the stability of PTH levels throughout the assay. Concerning vitamin D status, the Institute of Medicine has recently concluded that, based on bone health, serum 25OHD levels of 50 nmol/L cover the requirements of at least 97.5 % of the population [26] . However, there is controversy regarding the concentration of serum 25OHD required to reach an optimal vitamin D status to cover nonclassical functions of vitamin D, which include cancer, cardiovascular disease, diabetes, and autoimmune disorders [27] . Hollick 2008 [1] defined deficient vitamin D status as a circulating 25OHD concentration below 50 nmol/L (20 ng/mL), insufficient status between 51 and 74 nmol/L (21-29 ng/mL), and sufficient status over 75 nmol/L (30 ng/mL). According to these criteria, we found that 41 % of all of our volunteers were vitamin D deficient, 36 % were insufficient, and only 24 % were in a sufficient status. Therefore, 77 % of our volunteers presented vitamin D deficiency or insufficiency. This prevalence is higher than described previously for Spanish adolescent women (63 %) [28] and Spanish young adults (61 %) [29] , but lower than observed in a group of iron-deficient Spanish menstruating women, also recruited during the winter season, who presented a prevalence of 92 % of vitamin D deficiency or insufficiency [8] . The main cause of vitamin D deficiency is low exposure to sunlight. However, there are several other factors that can affect vitamin D status such as ageing, obesity, medications (antiseizure, glucocorticoids, or fat malabsorption medications), and the fact that few foods naturally contain this vitamin [1] . The group of volunteers selected for the study were healthy young women, with BMI within normal limits. Therefore, this high prevalence of vitamin D deficiency or insufficiency could be attributed to the fact that the dietary vitamin D intake of the volunteers did not reach the RDA for this population group, which at present is 200 IU (5 lg/day) [26, 30] , and to the fact that the analysis of the volunteers was performed in the winter season. A high prevalence of inadequate dietary vitamin D intake was also observed in general adult population in Europe when the estimated average requirement (EAR) cut-off point was applied [31] .
Regarding other nutrients that are related to bone health, the three groups of women presented similar baseline intakes of energy, macro-, and micronutrients. Iron intake was below the RDA for this population group (18 mg/day) [21, 22] . Vitamin K intake, necessary for bone health, was sufficient, according to the adequate intake (90 lg/day) [21] . Average magnesium intake is above the EAR value, phosphorus was higher than recommended, and in contrast calcium intake almost achieved 100 % of the RDA (1,000 mg/day) [22] . Consequently, Ca/P ratio was only 0.68, much lower than the recommended ratio of 1.3 [32] for optimal bone health. In many countries, low Ca/P ratios have been reported and it is known that excessive intake of phosphorous together with low dietary calcium may lead to an unfavourable imbalance in bone metabolism by inducing PTH secretion, which increases urinary phosphorous excretion but simultaneously increases bone resorption and reduces bone formation [33] .
The intervention with the fortified skimmed milk drinks implied an extra intake of calcium and iron in both groups, and of vitamin D in the Fe?D group. Consumption of the vitamin D-fortified product during 4 months decreased both P1NP and NTx, in agreement with the described effects of this vitamin in the reduction in bone turnover [34] . The additional amount of vitamin D consumed in the Fe?D group was 5 lg/day (200 IU) that, together with the intake from the usual diet (Table 1) , made a total of approximately 8 lg (300 IU) consumed daily. The present study shows that this consumption during 16 weeks was capable of increasing 25OHD mean levels to near the optimal value of 75 nmol/L [1] . However, at the end of the assay, NTx values of the Fe?D group did not reach the levels of the reference group. This could be due to the iron deficiency, as the iron-fortified dairy products were not effective in improving iron status, determined by the principal variable that reflects iron stores, serum ferritin [7] . The iron salt used to fortify the skimmed milks of the present study was microencapsulated iron pyrophosphate, and our research group previously demonstrated that this form of iron added to fruit juices clearly improved iron status in iron-deficient menstruating women and the beneficial effects were detected from the first month of intervention [35] . However, this form of iron in the flavoured skimmed milk is not absorbed due to the presence of casein and calcium, inhibitors of iron absorption, and absence of enhancers. Therefore, since this iron-fortified food did not increase iron status, the effect of iron on bone biomarkers could not be observed. Further studies are needed to clarify the role of iron supplementation on bone metabolism in different situations such as iron deficiency anaemia and osteoporosis, and in the case of fortified food using a food matrix that does not impair iron absorption.
To sum up, it was observed that iron deficiency is related with altered bone remodelling with markedly increased bone resorption in young women. Consumption of the iron and vitamin D-fortified skimmed milk reduced bone turnover and was successful in increasing circulating 25OHD to nearly reach an optimal vitamin D status.
